Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03698006Completed
Randomised, double-blind trial of ropivacaine in postoperative pain (2 arms), sponsored by Lausanne University Hospital. Primary endpoint: Total morphine consumption at 24 hours. Started Feb 2021; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03698006.